QLINEA Q-linea AB (publ)

1.117USD11.35 SEK · STO-8.84%Mkt Cap: 21.17M USDP/E: —

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland…

Key Statistics

Company
Market Cap21.17M USD
Enterprise Value7.99M USD
Revenue (TTM)1.53M USD
Gross Profit-166.64K USD
Net Income (TTM)-17.96M USD
Revenue/Share0.09 USD
Last Price1.117 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees66
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0025420714
Valuation
P/E (Trailing)—
P/E (Forward)-37.83
PEG—
EV/EBITDA-0.64
EV/Revenue5.22
P/S13.83
P/B0.88
EPS (TTM)-0.85 USD
EPS (Forward)-0.03 USD
52W Range
1.0632% of range3.782
52W High3.782 USD
52W Low1.063 USD
Profitability
Gross Margin-15.26%
Oper. Margin-918.43%
EBITDA Margin0.00%
Profit Margin-1644.31%
ROE-53.99%
ROA-49.36%
ROIC-205.06%
ROCE-51.73%
Growth
Revenue Growth38.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.96M USD
CapEx (TTM)744.23K USD
FCF Margin-592.24%
FCF Yield-42.82%
Net Debt-13.18M USD
Net Debt/EBITDA1.05
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio12.04
Quick Ratio8.54
Book Value/Sh1.27 USD
Cash/Share0.78 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateJul 14, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.95M
Float11.64M
Insiders28.55%
Institutions60.06%
Technical
SMA 501.588 (-29.6%)
SMA 2001.840 (-39.3%)
Beta0.50
S&P 52W Chg12.00%
Avg Vol (30d)7.92K
Avg Vol (10d)7.58K
Technical Indicators
RSI (14)16.2
MACD-1.1089
MACD Signal-0.9334
MACD Hist.-0.1755
BB Upper1.618 USD
BB Middle1.382 USD
BB Lower1.145 USD
BB Width34.20%
ATR (14)0.0671 USD
Vol Ratio (20d)4.54x

About Q-linea (STO: QLINEA)

›

Q-linea (STO: QLINEA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 66 employees.

The shares were at 11.35 SEK on 19 November 2026, down 54.5% over 52 weeks. Its 52-week range is 10.80 SEK to 38.42 SEK: the price is 70.5% below the high and 5.1% above the low.

Its market capitalisation is 215.07M SEK.

Q-linea reports return on equity of -54.0% and revenue up 38.2% year over year.

It holds more cash than debt, a net cash position of 133.85M SEK. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.